Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hisamitsu Of Japan Sees 46 Percent Profit Increase By Early 2014

This article was originally published in PharmAsia News

Executive Summary

Japan's Hisamitsu Pharmaceutical has mapped out a business plan it says should triple the company's stock dividends by February 2014. Hisamitsu credits its recent acquisition of U.S. drug maker Noven Pharmaceutical. That purchase, Hisamitsu said, helped drive up earnings, and it now expects a net profit by the end of fiscal 2013 that is anticipated to be 46 percent higher than projected for fiscal 2008. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts